Published On: Mon, Jun 1st, 2015

USAID Global Health Development Innovation Accelerator

Deadline: 22 June 2015

The Broad Agency Announcement (BAA) in support of The United States Agency for International Development (USAID) Global Health Development innovation is seeking opportunities to co-create, co-design, co- invest, and collaborate in the development, testing, and scaling of innovative approaches that address critical global health challenges.

This BAA is a competitive approach to consider proposals that harness scientific research and innovation to help prevent and manage critical global health challenges, allowing USAID and other funding Partners to:

  1. Reach out to potential partners with recognized expertise in relevant areas, and
  2. Co-create, co-design, co-invest, and collaborate with partners.

Objective

The agency wants to provide innovative interventions and technologies that further can work on the U.S. Government’s (USG) commitment to prevent and manage a critical global health challenge; the treatment of HIV positive people.

Awards

Multiple awards are anticipated. The amount of resources made available under this BAA will depend on the concepts received and the availability of funds.

Eligibility Criteria

  • Applicants that have experience in at least three among the areas related to
    • Alternative modes of ART delivery
    • Innovative approaches and more effective technologies for viral load monitoring
    • Use of technology and innovative programmatic strategies to enable more effective linkage activities from diagnosis to treatment
    • Successful care and treatment approaches that directly respond to the needs of key populations as measured by increases in the number of HIV+ individuals in key population groups that are on treatment and retained in care.
    • Promising “Test and Treat” strategies and the cost-effectiveness of models used
    • Exploration of new antiretroviral drug regimens which are simpler to use, have a more robust resistance barrier, are less expensive to manufacture.
  • Organizations that have a proven track record of success in the provision of HIV care and treatment service.
  • Organizations that have evidence based results in working with host country national and subnational government’s care and treatment programs
  • Organizations that meet the USAID Forward criteria for local organizations with experience of working in geographic regions with high HIV prevalence and burden.
  • Given the burden and indigenous management of the epidemic, preference will be given to African organizations.
  • Demonstrated experience in developing innovative approaches along the continuum of care from patient identification to long term retention in care.
  • Generic pharmaceutical companies and other organizations with evidence based, promising, new and innovative approaches regarding development, testing and manufacturing, registering, and introducing new and improved ARV regimens.

How to Apply

Interested applicants can submit an Expression of Interest (EoI) in English at given website.

Selected Applicants will be invited to join the co-design process which will consist of a co-creation workshop(s) in Washington, DC, where USAID, partners, and selected groups will gather to collaboratively develop the program(s).

For more information, please visit grants.gov and search for the opportunity number BAA-OAA-GH-2015.

828 total views, 3 views today